A new study finds that popular weight loss drug #Ozempic "could be profitably produced for less than $5 a month, even as maker Novo Nordisk A/S charges almost $1,000 in the US..."
The company's combined 2023 sales of Ozempic and related product Wegovy topped $18 billion.
